Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002432526 | SCV002731258 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-05-03 | criteria provided, single submitter | clinical testing | The c.2155delA pathogenic mutation, located in coding exon 13 of the DICER1 gene, results from a deletion of one nucleotide at nucleotide position 2155, causing a translational frameshift with a predicted alternate stop codon (p.T719Lfs*39). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Labcorp Genetics |
RCV005097977 | SCV005841622 | pathogenic | DICER1-related tumor predisposition | 2025-01-21 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr719Leufs*39) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DICER1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1786809). For these reasons, this variant has been classified as Pathogenic. |